EichorEICHOR
Location: Greenbrae Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Greenbrae

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Marin Cancer Care Inc · Hoffmann-La Roche · NCT06793215A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · NorCal Medical Research /ID# 256512 · AbbVie · NCT06345339An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participant
Phase 2 · NorCal Medical Research, Inc · Eli Lilly and Company · NCT07589608A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Phase 3 · NorCal Medical Research, Inc · Eli Lilly and Company · NCT07282600Pragmatic Trial of Psilocybin Therapy in Palliative Care
Phase 2 · Marin Cancer Care · Charles S. Grob, M.D. · NCT05403086Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · Marin Cancer Care Inc · National Cancer Institute (NCI) · NCT03866382A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupil
Phase 3 · NorCal Medical Research /ID# 278397 · AbbVie · NCT06389136A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Phase 3 · Research Site · AstraZeneca · NCT05774951A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
Phase 3 · Marin Cancer Care · Incyte Corporation · NCT07623200A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer
Phase 3 · Marin Cancer Care · Eli Lilly and Company · NCT07174336A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Phase 2 · Marin Cancer Care · Eli Lilly and Company · NCT07169851A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, f
Phase 2 · Marin Cancer Center · Janssen Research & Development, LLC · NCT06667076A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Particip
Phase 3 · Marin Cancer Care Inc · Hoffmann-La Roche · NCT06065748A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesit
Phase 2 · NorCal Medical Research, Inc · Eli Lilly and Company · NCT06143956A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Phase 1 · Marin Cancer Care · Bristol-Myers Squibb · NCT06997029Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
NA · Marin Cancer Care · Natera, Inc. · NCT07214532
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.